Patents by Inventor Bharat Trivedi

Bharat Trivedi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160083412
    Abstract: The invention relates to ketolide compounds of Formula (1) and their pharmaceutically acceptable salts, solvates, hydrates, polymorphs and stereoisomers having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compounds of invention, wherein, T is —C*H(R1)—P-Q; R, is hydrogen; unsubstituted or substituted lower alkyl, cycloalkyl or aryl; P is heteroaryl ring; Q is unsubstituted or substituted aryl or heteroaryl ring; and P is attached to Q via carbon-carbon link; and R3 is hydrogen or fluorine, With the provision that when R, is hydrogen, R3 is fluorine.
    Type: Application
    Filed: September 19, 2015
    Publication date: March 24, 2016
    Inventors: Bharat TRIVEDI, Prasad Deshpande, Ravikumar Tadiparthi, Sunil Gupta, Santosh Diwakar, Shivaji Pawar, Vijay Patil, Deepak Dekhane, Mahesh Patel, Satish Bhavsar, Amit Mishra, Manish Solanki, Mohammad Jafri, Sachin Bhagwat
  • Patent number: 9175031
    Abstract: The invention relates to ketolide compounds of Formula (I) and their pharmaceutically acceptable salts, solvates, hydrates, polymorphs and stereoisomers having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compounds of invention, wherein, T is —C*H(R1)—P-Q; R1 is hydrogen; unsubstituted or substituted lower alkyl, cycloalkyl or aryl; P is heteroaryl ring; Q is unsubstituted or substituted aryl or heteroaryl ring; and P is attached to Q via carbon-carbon link; and R3 is hydrogen or fluorine, With the provision that when R1 is hydrogen, R3 is fluorine.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: November 3, 2015
    Assignee: WOCKHARDT LIMITED
    Inventors: Bharat Trivedi, Prasad Deshpande, Ravikumar Tadiparthi, Sunil Gupta, Santosh Diwakar, Shivaji Pawar, Vijay Patil, Deepak Dekhane, Mahesh Patel, Satish Bhavsar, Amit Mishra, Manish Solanki, Mohammad Jafri, Sachin Bhagwat
  • Publication number: 20140005133
    Abstract: The invention relates to ketolide compounds of Formula (I) and their pharmaceutically acceptable salts, solvates, hydrates, polymorphs and stereoisomers having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compounds of invention, wherein, T is —C*H(R1)—P-Q; R1 is hydrogen; unsubstituted or substituted lower alkyl, cycloalkyl or aryl; P is heteroaryl ring; Q is unsubstituted or substituted aryl or heteroaryl ring; and P is attached to Q via carbon-carbon link; and R3 is hydrogen or fluorine, With the provision that when R1 is hydrogen, R3 is fluorine.
    Type: Application
    Filed: February 3, 2011
    Publication date: January 2, 2014
    Inventors: Bharat Trivedi, Prasad Deshpande, Ravikumar Tadiparthi, Sunil Gupta, Santosh Diwakar, Shivaji Pawar, Vijay Patil, Deepak Dekhane, Mahesh Patel, Satish Bhavsar, Amit Mishra, Manish Solanki, Mohammad Jafri, Sachin Bhagwat
  • Publication number: 20070088069
    Abstract: Novel imidazole compounds and pharmaceutical compositions are described, as are methods of using such compounds, alone or in combination with another pharmaceutically active agent, to treat subjects, including humans, suffering from hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and atherosclerosis.
    Type: Application
    Filed: October 11, 2006
    Publication date: April 19, 2007
    Inventors: Xue-Min Cheng, Richard Hutchings, Walter Howard, Robert Kennedy, William Park, Yuntao Song, Bharat Trivedi
  • Publication number: 20060287378
    Abstract: Novel imidazoles and novel pyrroles are provided. Also provided are pharmaceutical compositions, methods of making and methods of using the compounds.
    Type: Application
    Filed: March 24, 2006
    Publication date: December 21, 2006
    Inventors: Gary Bolton, Daniel Bowles, David Boyles, Walter Howard, Richard Hutchings, Robert Kennedy, William Park, Yuntao Song, Bharat Trivedi
  • Publication number: 20050171163
    Abstract: The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.
    Type: Application
    Filed: May 21, 2003
    Publication date: August 4, 2005
    Inventors: Larry Bratton, Alexander Bridges, David Connor, Steven Miller, Yuntao Song, Kuai-Lin Sun, Bharat Trivedi, Paul Unangst
  • Publication number: 20050154042
    Abstract: HMGCo-A reductase inhibitor compounds useful as hypocholesterolemic and hypolipidemic compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compounds are also provided.
    Type: Application
    Filed: December 2, 2004
    Publication date: July 14, 2005
    Inventors: Larry Bratton, Xue-Min Cheng, Chitase Lee, Steven Miller, Jeffrey Pfefferkorn, Toni-Jo Poel, Roderick Sorenson, Yuntao Song, Kuai-Lin Sun, Bharat Trivedi, Paul Unangst
  • Publication number: 20050153996
    Abstract: This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as methods of supressing appetite and modulating leptin levels in a mammal. The present invention also discloses methods for making the disclosed compounds.
    Type: Application
    Filed: November 2, 2004
    Publication date: July 14, 2005
    Inventors: Bruce Auerbach, Larry Bratton, Gary Filzen, Andrew Geyer, Bharat Trivedi, Paul Unangst
  • Publication number: 20050113422
    Abstract: This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing hyperlipidemia and hypercholesteremia in a mammal. The present invention also discloses method for making the disclosed compounds.
    Type: Application
    Filed: December 22, 2004
    Publication date: May 26, 2005
    Inventors: Xue-Min Cheng, Gary Filzen, Andrew Geyer, Chitase Lee, Bharat Trivedi
  • Publication number: 20050113440
    Abstract: This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing disipidemia, hypercholesteremia, obesity, eating disorders, hyperglycemia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia and diabetes in a mammal as well as methods of supressing appetite and modulating leptin levels in a mammal. The present invention also discloses methods for making the disclosed compounds.
    Type: Application
    Filed: November 2, 2004
    Publication date: May 26, 2005
    Inventors: Bruce Auerbach, Larry Bratton, Gary Filzen, Andrew Geyer, Bharat Trivedi, Paul Unangst
  • Publication number: 20050107442
    Abstract: This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing hyperlipidemia and hypercholesteremia in a mammal. The present invention also discloses method for making the disclosed compounds.
    Type: Application
    Filed: December 24, 2004
    Publication date: May 19, 2005
    Inventors: Xue-Min Cheng, Gary Filzen, Andrew Geyer, Chitase Lee, Bharat Trivedi
  • Publication number: 20050075348
    Abstract: Disclosed are novel compounds having the formula or a physiologically acceptable salt, amide, ester or prodrug thereof. The compounds can be used to modulate (antagonize, agonize) chemokine receptor function. Also disclosed is a method for treating a patient having an inflammatory disease and/or viral infection comprising administering an effective amount of a compound of Formula I. In particular embodiments, the invention is a method for treating a patient infected with HIV.
    Type: Application
    Filed: November 8, 2004
    Publication date: April 7, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Geraldine Harriman, Kenneth Carson, Daniel Flynn, Michael Solomon, Yuntao Song, Bharat Trivedi, Bruce Roth, Christine Kolz, Ly Pham, Kuai-lin Sun
  • Publication number: 20050043364
    Abstract: 50 HMGCo-A reductase inhibitor compounds useful as hypocholesterolemic and hypolipidemic compounds are provided. Also provided are pharmaceutical compositions of the compounds. Methods of making and methods of using the compounds are also provided.
    Type: Application
    Filed: June 7, 2004
    Publication date: February 24, 2005
    Inventors: Robert Kennedy, William Park, Bruce Roth, Yuntao Song, Bharat Trivedi
  • Patent number: 4714697
    Abstract: N.sup.6 -Bicyclo adenosines and pharmaceutically acceptable acid addition salts having highly desirable antiinflammatory and analgesic activity and processes for their manufacture as well as pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: September 9, 1985
    Date of Patent: December 22, 1987
    Assignee: Warner Lambert Company
    Inventor: Bharat Trivedi
  • Patent number: 4657898
    Abstract: N.sup.6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: July 18, 1985
    Date of Patent: April 14, 1987
    Assignee: Warner-Lambert Company
    Inventors: James A. Bristol, Walter H. Moos, Bharat Trivedi
  • Patent number: 4657897
    Abstract: N.sup.6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: July 17, 1985
    Date of Patent: April 14, 1987
    Assignee: Warner-Lambert Company
    Inventors: James A. Bristol, Walter H. Moos, Bharat Trivedi
  • Patent number: 4501735
    Abstract: N.sup.6 -(1 and 2-Benzocycloalkyl)adenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, process for their manufacture, pharmaceutical compositions and methods for using said compounds and compositions are described.
    Type: Grant
    Filed: December 5, 1983
    Date of Patent: February 26, 1985
    Assignee: Warner-Lambert Company
    Inventors: Bharat Trivedi, Harriet Hamilton, Walter Moos